Iva Lukač

Clinical and veterinary trypanocidal benzoxaboroles target CPSF3

Richard J. Wall, Eva Rico, Iva Lukač et al. · Proceedings of the National Academy of Sciences · 2018 · 130 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis

Charles E. Mowbray, Stéphanie Braillard, Paul A. Glossop et al. · Journal of Medicinal Chemistry · 2021 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis

Michael G. Thomas, Stephen Brand, Manu De Rycker et al. · Journal of Medicinal Chemistry · 2021 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity

Simon R. Green, Caroline Wilson, T.C. Eadsforth et al. · Journal of Medicinal Chemistry · 2023 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

SophosQM: Accurate Binding Affinity Prediction in Compound Optimization

Riccardo Guareschi, Iva Lukač, Ian H. Gilbert et al. · ACS Omega · 2023 · 19 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17